BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19188908)

  • 1. Rapid diagnosis of human prion disease using streptomycin with tonsil and brain tissues.
    Quadrio I; Ugnon-Café S; Dupin M; Esposito G; Streichenberger N; Krolak-Salmon P; Vital A; Pellissier JF; Perret-Liaudet A; Perron H
    Lab Invest; 2009 Apr; 89(4):406-13. PubMed ID: 19188908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.
    Hill AF; Butterworth RJ; Joiner S; Jackson G; Rossor MN; Thomas DJ; Frosh A; Tolley N; Bell JE; Spencer M; King A; Al-Sarraj S; Ironside JW; Lantos PL; Collinge J
    Lancet; 1999 Jan; 353(9148):183-9. PubMed ID: 9923873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion early kinetics revisited using a streptomycin-based PrP(res) extraction method.
    Leclere E; Moussa A; Chouaf-Lakhdar L; Coleman AW; Seigneurin JM; Perron H; Bencsik A
    Biochem Biophys Res Commun; 2008 Aug; 372(3):429-33. PubMed ID: 18489903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prion diseases or transmissible spongiform encephalopathies].
    Brandel JP
    Rev Med Interne; 2022 Feb; 43(2):106-115. PubMed ID: 34148672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive detection of PrPSc by Western blot assay based on streptomycin sulphate precipitation.
    Dong CF; Huang YX; An R; Chen JM; Wang XF; Shan B; Lei YJ; Han L; Zhang BY; Han J; Dong XP
    Zoonoses Public Health; 2007; 54(8):328-36. PubMed ID: 17894644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid screening and confirmatory methods for biochemical diagnosis of human prion disease.
    Ugnon-Café S; Dorey A; Bilheude JM; Streichenberger N; Viennet G; Meyronet D; Maues de Paula A; Perret-Liaudet A; Quadrio I
    J Virol Methods; 2011 Aug; 175(2):216-23. PubMed ID: 21619894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease.
    Ironside JW; Head MW
    Curr Top Microbiol Immunol; 2004; 284():133-59. PubMed ID: 15148991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
    Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
    Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment of an assay for PrP(Sc) detection based on streptomycin precipitation].
    Dong CF; Huang YX; An R; Chen JM; Wang XF; Shan B; Lei YJ; Han L; Zhang BY; Han J; Dong XP
    Bing Du Xue Bao; 2008 May; 24(3):185-9. PubMed ID: 18683554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases.
    Schulz-Schaeffer WJ; Tschöke S; Kranefuss N; Dröse W; Hause-Reitner D; Giese A; Groschup MH; Kretzschmar HA
    Am J Pathol; 2000 Jan; 156(1):51-6. PubMed ID: 10623653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting.
    Ritchie DL; Head MW; Ironside JW
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):360-8. PubMed ID: 15305981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease.
    Head MW; Northcott V; Rennison K; Ritchie D; McCardle L; Bunn TJ; McLennan NF; Ironside JW; Tullo AB; Bonshek RE
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):342-6. PubMed ID: 12506094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.
    Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA
    Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-assessment of PrP(Sc) distribution in sporadic and variant CJD.
    Rubenstein R; Chang B
    PLoS One; 2013; 8(7):e66352. PubMed ID: 23843953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.
    Wadsworth JD; Joiner S; Hill AF; Campbell TA; Desbruslais M; Luthert PJ; Collinge J
    Lancet; 2001 Jul; 358(9277):171-80. PubMed ID: 11476832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.
    Uro-Coste E; Cassard H; Simon S; Lugan S; Bilheude JM; Perret-Liaudet A; Ironside JW; Haik S; Basset-Leobon C; Lacroux C; Peoch' K; Streichenberger N; Langeveld J; Head MW; Grassi J; Hauw JJ; Schelcher F; Delisle MB; Andréoletti O
    PLoS Pathog; 2008 Mar; 4(3):e1000029. PubMed ID: 18389084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
    Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
    Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study.
    Head MW; Ritchie D; Smith N; McLoughlin V; Nailon W; Samad S; Masson S; Bishop M; McCardle L; Ironside JW
    Am J Pathol; 2004 Jan; 164(1):143-53. PubMed ID: 14695328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CJD PrPsc removal by nanofiltration process: application to a therapeutic immunoglobulin solution (Lymphoglobuline).
    Truchot L; Arnaud T; Bloy C; Perret-Liaudet A
    Biologicals; 2006 Sep; 34(3):227-31. PubMed ID: 16490361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.